| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/04/2002 | US20020086000 Stimulation of thymus for vaccination development |
| 07/04/2002 | US20020085995 In vivo induction for enhanced function of isolated hepatocytes |
| 07/04/2002 | US20020085978 Containing a propellant, a cosolvent, and a radical quencher. |
| 07/04/2002 | US20020085615 Differential scanning calorimeter |
| 07/04/2002 | US20020084230 Methods for screening drugs to predict tardive dyskinesia |
| 07/04/2002 | DE10064994A1 Sulfamidothienopyrimidine Sulfamidothienopyrimidine |
| 07/04/2002 | DE10064993A1 Drug formulation useful e.g. for treating angina or hypertension contains pyrazolo (4,3-d) pyrimidine derivative phosphodiesterase V inhibitor and antithrombotic agent, calcium antagonist or prostaglandin |
| 07/04/2002 | DE10059144A1 Modulation der Transkription pro-inflammatorischer Genprodukte Modulating the transcription of pro-inflammatory gene products |
| 07/04/2002 | DE10037759A1 Screeningverfahren Screening method |
| 07/04/2002 | CA2847458A1 Defects in periaxin associated with myelinopathies |
| 07/04/2002 | CA2782510A1 Polypeptides |
| 07/04/2002 | CA2441896A1 Quinuclidine carbamate derivatives and their use as m3 antagonists |
| 07/04/2002 | CA2436777A1 A screening assay for antagonists of human leukocyte receptors |
| 07/04/2002 | CA2436739A1 Combination agent |
| 07/04/2002 | CA2432977A1 New use of artemin, a member of the gdnf ligand family |
| 07/04/2002 | CA2432693A1 Identification of modulators of dham-kinase and inflammatory diseases |
| 07/04/2002 | CA2432683A1 Screening method based on siah-numb interaction |
| 07/04/2002 | CA2432644A1 Pharmaceutical composition comprising aspirintm and cs-747 |
| 07/04/2002 | CA2432543A1 Combination drugs |
| 07/04/2002 | CA2432542A1 Methods of modulating toll-related receptor (trr) signaling |
| 07/04/2002 | CA2432415A1 Acetyl-coenzyme a carboxylase 2 as a target in fat regulation and insulin action |
| 07/04/2002 | CA2432214A1 Gene involved in apoptosis regulation |
| 07/04/2002 | CA2432168A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/04/2002 | CA2431916A1 New therapeutic uses of smr1 peptides |
| 07/04/2002 | CA2431913A1 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 07/04/2002 | CA2431835A1 Induction of tolerance |
| 07/04/2002 | CA2430930A1 Helicobacter proteins, nucleic acids and uses thereof |
| 07/04/2002 | CA2430719A1 A method of assaying for agonists or antagonist of dynorphin a binding to the mas receptor |
| 07/04/2002 | CA2430610A1 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
| 07/04/2002 | CA2399280A1 Defects in periaxin associated with myelinopathies |
| 07/03/2002 | EP1219716A2 Diacylglycerol acyltransferase (DGAT) assay |
| 07/03/2002 | EP1219638A2 G-protein coupled receptors having homology to the P2Y purinoreceptor 1 (P2Y1) |
| 07/03/2002 | EP1219622A2 Pharmaceutical compositions for CNS and other disorders |
| 07/03/2002 | EP1218751A2 Diagnosis of coeliac disease using a gliadin epitope |
| 07/03/2002 | EP1218747A1 Method for identifying compounds useful in the therapy of bone disorders |
| 07/03/2002 | EP1218742A1 Spa in a screening method for modulators of glucokinase |
| 07/03/2002 | EP1218544A1 Methods for identifying rna binding compounds |
| 07/03/2002 | EP1218540A2 Transposon mediated differential hybridisation |
| 07/03/2002 | EP1218538A2 Cancer associated antigens and uses therefor |
| 07/03/2002 | EP1218518A1 Dna polymerase lambda and uses thereof |
| 07/03/2002 | EP1218515A2 Regulation with binding cassette transporter protein abc1 |
| 07/03/2002 | EP1218511A1 Antimicrobial compositions |
| 07/03/2002 | EP1218509A2 Fibroblast growth factor-like polypeptides |
| 07/03/2002 | EP1218506A1 Traf4 associated cell cycle proteins, compositions and methods of use |
| 07/03/2002 | EP1218502A2 Nicotinic acetylcholine receptor : alpha10 subunit |
| 07/03/2002 | EP1218498A1 Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles |
| 07/03/2002 | EP1218496A2 DIAGNOSTIC PROBES AND THERAPEUTICS TARGETING uPA AND uPAR |
| 07/03/2002 | EP1218494A2 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 07/03/2002 | EP1218493A1 Isolated dishevelled associated kinases, polynucleotides encoding the kinases, and methods of use thereof |
| 07/03/2002 | EP1218491A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 07/03/2002 | EP1218412A2 Human g-protein coupled receptor |
| 07/03/2002 | EP1218401A1 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use |
| 07/03/2002 | EP1218381A2 AMINO SUBSTITUTED PYRAZOLO 1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO 1,5-a]-1,3,5-TRIAZINES |
| 07/03/2002 | EP1218379A2 CERTAIN ALKYLENE DIAMINE-SUBSTITUTED PYRAZOLO 1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO 1,5-a]-1,3,5-TRIAZINES |
| 07/03/2002 | EP1218376A1 Tyrosine kinase inhibitors |
| 07/03/2002 | EP1218368A1 COMPOSITIONS AND METHODS FOR MODULATING APOPTOSIS IN CELLS OVER-EXPRESSING bcl-2 FAMILY MEMBER PROTEINS |
| 07/03/2002 | EP1218361A1 Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 07/03/2002 | EP1218360A1 Triazine kinase inhibitors |
| 07/03/2002 | EP1218064A2 Compositions for treating autoimmune disease containing a compounds which regulates icam-lfa-1 interaction and a compounds which regulates cd40-cd40 ligand interaction |
| 07/03/2002 | EP1218063A2 Pharmaceutical composition containing trichloroacetic acid, 2-oh benzoic acid and menthol for topical application, uses and process for the preparation thereof |
| 07/03/2002 | EP1218049A2 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 07/03/2002 | EP1218036A1 Cell based assay |
| 07/03/2002 | EP1218032A1 Treatment of refractory human tumors with epidermal growth factor receptor antagonists |
| 07/03/2002 | EP1218023A2 Method for calming human beings using personal care compositions |
| 07/03/2002 | EP1218015A2 Pharmaceutical composition of nateglinide and another antidiabetic agent |
| 07/03/2002 | EP1218013A2 Phospholipid prodrugs of anti-proliferative drugs |
| 07/03/2002 | EP1218011A1 Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes, dna viruses and retroviruses |
| 07/03/2002 | EP1218007A1 Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| 07/03/2002 | EP1218005A2 Vitronectin receptor antagonists |
| 07/03/2002 | EP1218002A1 Use of flavone 8-acetic acid in vascular and cardiovascular interventions and acute coronary syndromes |
| 07/03/2002 | EP1218001A1 Ultrafine l-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same |
| 07/03/2002 | EP1217993A2 Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
| 07/03/2002 | EP1217990A1 Cationic dosper virosomes |
| 07/03/2002 | EP1217988A1 Proteinic drug delivery system using membrane mimetics |
| 07/03/2002 | EP1217963A1 Devices and methods for treating tissue |
| 07/03/2002 | EP1217893A1 Method for improving immunity in plants and animals |
| 07/03/2002 | EP1131062A4 Injectable propofol formulations |
| 07/03/2002 | EP1063978A4 Method of treating neuroma pain |
| 07/03/2002 | EP0912085A4 Precise efficacy assay methods for active agents including chemotherapeutic agents |
| 07/03/2002 | EP0813423B1 Composition to inhibit osteolysis and metastasis |
| 07/03/2002 | CN1357048A Enhanced prodrug activation |
| 07/03/2002 | CN1357046A Chitinase chitin-binding fragments |
| 07/03/2002 | CN1357038A Combination of lactic acid bacteria and its use for prevention and/or treatment of infections and inflammatory conditions |
| 07/03/2002 | CN1357002A Compositions for treating inflammatory response |
| 07/03/2002 | CN1356977A Glucagon antagonists/inverse agonists |
| 07/03/2002 | CN1356906A Therapeutic methods and compsns. for treatment of in paired interpersonal and behavioral disorders |
| 07/03/2002 | CN1356892A Use of biodegradable microspheres for delivery of anticancer for treatment of glioblastoma |
| 07/03/2002 | CN1356883A Vacuum assisted closure system with provision for introduction of agent |
| 07/03/2002 | CN1356876A Compsns. containing creatine in suspension |
| 07/03/2002 | CN1356104A Antalgic method by general medicine application |
| 07/03/2002 | CN1086937C Method of inhibiting photoaging of skin |
| 07/02/2002 | US6414134 Regulation of bcl-2 gene expression |
| 07/02/2002 | US6414128 Leptin ligand binding; medical diagnosis, therapy, agonists, and antagonists; genetic engineering |
| 07/02/2002 | US6414126 C-aryl glucoside SGLT2 inhibitors and method |
| 07/02/2002 | US6414115 Parasitic nematode transglutaminase proteins and uses thereof |
| 07/02/2002 | US6414114 Useful as agents in oxidation-reduction equilibrium in cells; enzyme regulation in homeostasis |
| 07/02/2002 | US6414032 Anti-infective compositions for treating disordered tissue such as cold sores |
| 07/02/2002 | US6414027 Methods and compositions for treating male erectile dysfunction |
| 07/02/2002 | US6414018 Heart surgery; electricity pacing; administering adrenergic blocking agent |
| 07/02/2002 | US6414014 Calibration dosage; side effect reduction |